Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer
The pleiotropic protein hepatocyte growth factor (HGF) is the only known ligand of the tyrosine kinase mesenchymal–epithelial transition (cMET) receptor. The HGF/cMET pathway mediates invasion and migration of ovarian cancer cells, and upregulation of HGF/cMET pathway components has been associated...
Guardado en:
Autores principales: | Daniel Martin Klotz, Theresa Link, Pauline Wimberger, Jan Dominik Kuhlmann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf6cb568631c407b9309e6601d063dd2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
por: Claudia Desole, et al.
Publicado: (2021) -
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Ryota Tanaka, et al.
Publicado: (2021) -
HGF/c-Met regulates p22phox subunit of the NADPH oxidase complex in primary mouse hepatocytes by transcriptional and post-translational mechanisms
por: Arturo Simoni-Nieves, et al.
Publicado: (2021) -
Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification
por: Lin S, et al.
Publicado: (2021) -
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
por: Lu Zhang, et al.
Publicado: (2021)